Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T08:12:36.073Z Has data issue: false hasContentIssue false

Effect of Intermittent Theta-Burst Stimulation on Chronobiological Hypothalamic-Pituitary-Thyroid Axis Activity in Treatment-Resistant Depression

Published online by Cambridge University Press:  31 July 2026

F. Duval*
Affiliation:
Pole 8/9 - APF2R, Centre Hospitalier, Rouffach, France
M.-C. Mokrani
Affiliation:
Pole 8/9 - APF2R, Centre Hospitalier, Rouffach, France
V. Danila
Affiliation:
Pole 8/9 - APF2R, Centre Hospitalier, Rouffach, France
T. Weiss
Affiliation:
Pole 8/9 - APF2R, Centre Hospitalier, Rouffach, France
F. Gonzalez Lopera
Affiliation:
Pole 8/9 - APF2R, Centre Hospitalier, Rouffach, France
M. I. Tomsa
Affiliation:
Pole 8/9 - APF2R, Centre Hospitalier, Rouffach, France
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

The effects of intermittent theta-burst stimulation (iTBS), a form of repetitive transcranial magnetic stimulation, on the hypothalamic-pituitary-thyroid (HPT) axis are not well understood. This axis is frequently dysregulated in treatment-resistant depression (TRD). We previously demonstrated that the difference in thyrotropin (TSH) response to protirelin (TRH) between 23 h and 8 h on the same day (the ∆∆TSH test) is a highly sensitive chronobiological marker.

Objectives

To evaluate the impact of iTBS targeting the left dorsolateral prefrontal cortex (LDPFC) on chronobiological HPT activity in hospitalized TRD patients.

Methods

Twenty-three TRD inpatients with abnormal ∆∆TSH values (< 2.5 mU/L) and HAMD-17 scores ≥ 18 were compared to 23 matched healthy controls (HCs). Patients received 20 iTBS sessions (one per weekday over four weeks) while maintaining stable antidepressant treatment. The ∆∆TSH test and HAMD-17 scores were assessed pre- and post-treatment. Response was defined as a ≥ 50% reduction in HAMD-17.

Results

Baseline ∆∆TSH values were significantly lower in TRDs than in HCs (p < 0.00001, by U test). After iTBS treatment, patients showed a decrease in HAMD-17 scores (p = 0.0001, by T test) and an increase in ∆∆TSH values (p = 0.001, by T test)—although still remaining lower than those of HCs (p = 0.03, by U test). At endpoint, HAMD-17 scores correlated negatively with ∆∆TSH values (rho = -0.74, p = 0.0004). Fourteen patients (61%) normalized their ∆∆TSH, of whom 11 (78%) were responders; all patients who did not normalize their post-treatment ∆∆TSH (n = 9) were non-responders (p = 0.0003, by Fisher’s Exact test).

Conclusions

While the underlying mechanisms remain to be clarified, this pilot study suggests that successful iTBS treatment may help restore normal chronobiological function of the HPT axis in TRD patients, and that such restoration is associated with clinical improvement.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.